期刊文献+

液基细胞学联合HPV-DNA亚型检测对宫颈癌筛查的效果观察

下载PDF
导出
摘要 目的:探讨液基细胞学联合HPV-DNA亚型检测对宫颈癌筛查的效果。方法:选取2018年6月至2019年3月在本院进行宫颈癌筛查的1400例患者,均给予细胞DNA定量检测和宫颈液基细胞学TBS检查,一次取材,发两份报告,再联合HPV检查进行宫颈癌筛查。观察不同检测手段对于癌、CINⅢ、CINⅡ、CINⅠ以及炎症的阳性检测率。结果:两种手段联合使用的阳性检测率为81.29%(1138/1400),明显高于单独检测液基细胞学的73.14%(1024/1400)以及单独检测HPV-DNA亚型的67.71%(948/1400)(P<0.05)。结论:液基细胞学联合HPV-DNA亚型检测在宫颈癌的筛查中具有较高的价值。
作者 廉世萍
出处 《中外女性健康研究》 2019年第16期173-173,185,共2页 Women's Health Research
  • 相关文献

参考文献4

二级参考文献34

  • 1Jemal A, Bray F, Center MM, et al. Global cancer statistics [ J ]. A Cancer Journal For Clinicians,2011,61 (2) :69 -90.
  • 2Pecorelh S, Zigliani L, Odicino F. Revised FIGO staging for carcinoma of the cervix [ J ]. International Journal of Gynecology & Obstetrics, 2009,105 (2) : 107 - 108.
  • 3Raspagliesi F, Ditto A, Selvaggi L, et al. A phase 2 multicenter study of irinotecan and cisplatinum as neoadjuvant treatment in patients with locally advanced cervical cancer[ J ]. International Journal of Gyneco- logical Cancer,2010,20(9 ) : 1569 - 1575.
  • 4Selvaggi L, Loizzi V, Di Gilio AR, et al. Neoadjuvant chemotherapy in cervical cancer: a 67 patients experience [ J ]. International Journal of Gynecological Cancer,2006,16(2) :631 -637.
  • 5Kobayashi K, Furukawa A, Takahashi M, et al. Neoadjuvant intra-arte- rial chemotherapy for locally advanced uterine cervical cancer:clinical efficacy and factors influencing response [ J 1. Cardiovascular and In- terventional Radiology ,2003,26 ( 3 ) :234 - 241.
  • 6Huguet F, Cojocariu OM, Levy P, et al. Preoperative concurrent radia- tion therapy and chemotherapy for bulky stage Ib2, IIa, and IIb carci- noma of the uterine cervix with proximal parametrial invasion [ J ]. Int J Radiat Oncol Biol Phys ,2008,72 (5) : 1508 - 1515.
  • 7Cho YH, Kim DY, Kim JH, et al. Comparative study of neoadjuvant chemotherapy before radical hysterectomy and radical surgery alone in stage I B2- II A bulky cervical cancer[ J]. Journal of gynecologic on- cology,2009,20( 1 ) :22 -27.
  • 8Kim HS, Kim JY, Park NH, et al. Matched-case comparison for the ef- ficacy of neoadjuvant chemotherapy before surgery in FIGO stage I B1- ]l A cervical cancer [ J ]. Gynecol Oncol, 2010, 119 ( 2 ) : 217 - 224.
  • 9Eddy GL, Bundy BN, Creasman WT, et al. Treatment of( " bulky') stage IB cervical cancer with or without neoadjuvan vincristine and cisplatin prior to radical hysterectomy and pelvic/para-aortic lymph- adenectomy : a phase III trial of the gynecologic oncology group [ J 1. Gynecol Onco1,2007,106 ( 2 ) :362 - 369.
  • 10Choi YS, Sin JI, Kim JH, et al. Survival benefits of neoadjuvant chem- otherapy followed by radical surgery versus radiotherapy in locally ad- vanced chemoresistant cervical cancer[ J 1. Journal of Korean Medical Science,2006,21 (4) :685 - 689.

共引文献219

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部